SOM Biotech participated in the Euronext webinar “Finance your tech company´s growth through capital markets” next June 25th.
Raul Insa, CEO of SOM Biotech, was a keynote speaker sharing his experience and views on financing alternatives for a biotech company.
Raul Insa: “As CEO and founding partner of a growing biotech company, I have led different initiatives to raise funding at different stages of SOM Biotech´s growth. Currently, the company aims to strengthen its financing strategy and incorporate new qualified investors to accompany us in a new phase of expansion. Capital markets, and specially Euronext, offer ideal financing options for technology companies that want to attract investors specialized in technology and innovation.”
